Cyp2c69 Inhibitors

CYP2C69, a member of the cytochrome P450 enzyme family, exhibits diverse functions, including caffeine oxidase, heme binding, and monooxygenase activities. Predicted involvement in the epoxygenase P450 pathway and xenobiotic metabolic processes emphasizes its role in cellular homeostasis. Orthologous to CYP2C19 and CYP2C9, CYP2C69 is implicated in diseases such as Plasmodium falciparum malaria, eosinophilic esophagitis, glucose metabolism disease, invasive aspergillosis, and multiple chemical sensitivity. The search for inhibitors of CYP2C69 reveals a set of chemicals that may directly or indirectly modulate its activities. Ketoconazole and fluconazole act as direct inhibitors by interfering with monooxygenase activity, hindering the enzyme's participation in caffeine oxidase pathways. Disulfiram, an alcohol deterrent, indirectly inhibits CYP2C69 by impacting caffeine oxidase activity and disrupting intracellular membrane-bounded organelle functions, influencing the enzyme's predicted involvement in heme binding processes.

Cimetidine, ranitidine, and econazole, H2 receptor antagonists and an antifungal agent, respectively, either directly or indirectly inhibit CYP2C69 by modulating monooxygenase activity, influencing the enzyme's predicted participation in caffeine oxidase and heme binding pathways. Enoxacin, a fluoroquinolone antibiotic, directly affects caffeine oxidase activity, altering endoplasmic reticulum dynamics and hindering the enzyme's predicted participation in heme binding processes. Phenylbutazone and trimethoprim act as direct inhibitors by affecting monooxygenase and caffeine oxidase activities, respectively, modifying intracellular membrane dynamics and impacting the enzyme's predicted involvement in heme binding processes. Voriconazole and miconazole, antifungal drugs, either directly or indirectly inhibit CYP2C69 by interfering with monooxygenase activity, affecting the enzyme's participation in caffeine oxidase pathways. Understanding the role of CYP2C69 inhibitors provides valuable insights into the intricate functions of this enzyme and its involvement in cellular processes, contributing to the broader understanding of its implications in health and disease. Further research into these chemicals and their interactions with CYP2C69 offers avenues for interventions and advancements in our understanding of cellular metabolism.